← Eichor
Condition: Schizophrenia Patients Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Schizophrenia Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Bioequivalence Study of PP3M in Patients With Schizophrenia
NA · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07493551Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024Neural Biomarkers of Electroconvulsive Therapy Response
NA · 1 location(s) · Northwell Health · NCT04763655Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · 22 location(s) · Vanda Pharmaceuticals · NCT06961968Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spect
Phase 3 · 61 location(s) · Intra-Cellular Therapies, Inc. · NCT06229210PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas
NA · 1 location(s) · Nikolai Albert · NCT07242586Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder
NA · 1 location(s) · Medicalschool Hamburg · NCT06048172Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Phase 3 · 1 location(s) · Otsuka Pharmaceutical Co., Ltd. · NCT05325645Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients
NA · 5 location(s) · The Hong Kong Polytechnic University · NCT07441928Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
Phase 3 · 8 location(s) · Central South University · NCT07045142A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
Phase 3 · 1 location(s) · Otsuka Pharmaceutical Co., Ltd. · NCT07225712Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or B
NA · 2 location(s) · Vestre Viken Hospital Trust · NCT06197048MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Phase 2/Phase 3 · 3 location(s) · Mclean Hospital · NCT06191965The Hi-tACS on Cognitive Function in Patients With Schizophrenia
NA · 2 location(s) · Sir Run Run Shaw Hospital · NCT06470516Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06505668The Danish Region Midt Schizophrenia Cohort
Phase N/A · 5 location(s) · University of Aarhus · NCT06431009Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant
Phase 3 · 10 location(s) · Newron Pharmaceuticals SPA · NCT07184619Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients
NA · 1 location(s) · Nova Scotia Health Authority · NCT05365347Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Phase 4 · 1 location(s) · University of Massachusetts, Worcester · NCT06174116Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia
NA · 6 location(s) · University Hospital, Toulouse · NCT07055204Early Identification of Patients Presenting a First Psychotic Episode, Non Answering to First Line Support Strategies
Phase N/A · 5 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT02670447VR-based Avatar Therapy for Treatment of Auditory Hallucinations
NA · 4 location(s) · Semmelweis University · NCT06505564No Guts No Glory Probiotics
Phase 2/Phase 3 · 3 location(s) · University Medical Center Groningen · NCT07606014Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Phase 3 · 1 location(s) · Louisiana State University Health Sciences Center Shreveport · NCT06482554Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
NA · 1 location(s) · Boston VA Research Institute, Inc. · NCT05299749Autonomic Nervous System and Meridian Energy in Patients With Schizophrenia
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06617104Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized
Phase N/A · 1 location(s) · Akrivia Health · NCT06641726Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia
Phase N/A · 1 location(s) · Shanghai Mental Health Center · NCT05159349RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NA · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT0570458252-week Open Label Safety-Tolerability Study
Phase 3 · 23 location(s) · LB Pharmaceuticals Inc. · NCT07369154
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.